药明巨诺-B(02126)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02126 药明巨诺-B

休市中 11-14 16:08:09

3.620

-0.080

-2.16%

最高3.710	最低3.550	成交量126.20万
今开3.660	昨收3.700	日振幅4.32%
总市值15.06亿	流通市值15.06亿	总股本4.16亿
成交额456.99万	换手率0.30%	流通股本4.16亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02126","market":"HK","secType":"STK","nameCN":"药明巨诺-B","latestPrice":3.62,"timestamp":1763107689779,"preClose":3.7,"halted":0,"volume":1262000,"delay":0,"floatShares":416000000,"shares":416000000,"eps":-1.5630025301457728,"marketStatus":"休市中","change":-0.08,"latestTime":"11-14 16:08:09","open":3.66,"high":3.71,"low":3.55,"amount":4569905,"amplitude":0.043243,"askPrice":3.62,"askSize":1000,"bidPrice":3.57,"bidSize":2500,"shortable":0,"etf":0,"ttmEps":-1.6294275926763848,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1763343000000},"marketStatusCode":7,"adr":0,"listingDate":1604332800000,"exchange":"SEHK","adjPreClose":3.7,"openAndCloseTimeList":[[1763083800000,1763092800000],[1763096400000,1763107200000]],"volumeRatio":1.0015873016349963,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02126","defaultTab":"news","newsList":[{"id":"2583354591","title":"药明巨诺-B盘中异动 早盘大幅上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583354591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583354591?lang=zh_cn&edition=full","pubTime":"2025-11-13 09:35","pubTimestamp":1762997701,"startTime":"0","endTime":"0","summary":"2025年11月13日早盘09时35分，药明巨诺-B股票出现波动，股价大幅拉升5.10%。截至发稿，该股报3.710港元/股，成交量11.05万股，换手率0.03%，振幅2.55%。药明巨诺-B股票所在的生物技术行业中，整体涨幅为2.32%。其相关个股中，百济神州、来凯医药-B、药明巨诺-B涨幅较大，振幅较大的相关个股有映恩生物-B、来凯医药-B、歌礼制药-B，振幅分别为5.67%、4.36%、3.99%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113093501a49d9fff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113093501a49d9fff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","02126","BK1574"],"gpt_icon":0},{"id":"2581833959","title":"药明巨诺-B11月07日主力净流出54.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2581833959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581833959?lang=zh_cn&edition=full","pubTime":"2025-11-07 16:15","pubTimestamp":1762503345,"startTime":"0","endTime":"0","summary":"11月07日, 药明巨诺-B股价跌4.99%，报收3.43元，成交金额724.7万元，换手率0.51%，振幅3.60%，量比0.57。药明巨诺-B今日主力资金净流出54.3万元，上一交易日主力净流入45.3万元。该股近5个交易日下跌0.57%，主力资金累计净流出106.8万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出764.6万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107161948975a1813&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107161948975a1813&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02126","BK1161","BK1583","BK1574"],"gpt_icon":0},{"id":"2581739747","title":"中新健康丨2025年国谈收官 “天价抗癌疗法”或迎支付破局","url":"https://stock-news.laohu8.com/highlight/detail?id=2581739747","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581739747?lang=zh_cn&edition=full","pubTime":"2025-11-05 19:08","pubTimestamp":1762340901,"startTime":"0","endTime":"0","summary":"国家医保局8月公布了2025年国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整形式审查的申报药品名单。“天价抗癌疗法”或迎来支付破局在今年的商保创新药目录中，天价“CAR-T疗法”无疑成为最大看点。截至目前，国内已有7款CAR-T疗法获批上市，定价普遍在百万元以上，此次有5款CAR-T疗法通过了商保目录的形式审查，其中3款同时申报了两个目录。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105190826a6e30a05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105190826a6e30a05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","BK1574","BK1593","02171","BK1161","02126","06978","02196"],"gpt_icon":0},{"id":"2581056694","title":"药明巨诺-B11月05日主力净流出16.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2581056694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581056694?lang=zh_cn&edition=full","pubTime":"2025-11-05 16:15","pubTimestamp":1762330549,"startTime":"0","endTime":"0","summary":"11月05日, 药明巨诺-B股价跌4.89%，报收3.50元，成交金额863.1万元，换手率0.59%，振幅4.89%，量比0.61。药明巨诺-B今日主力资金净流出16.0万元，上一交易日主力净流入11.4万元。该股近5个交易日下跌2.22%，主力资金累计净流出194.5万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出780.7万元，其中净流出天数为9日。该股主力净额占比0.01%，港股市场排名2416/2683。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105162031a48a0852&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105162031a48a0852&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","BK1574","02126"],"gpt_icon":0},{"id":"2581061713","title":"恒生医疗保健指数跌0.3% 医药股普遍走低 圣诺医药-B(02257)跌8.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581061713","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581061713?lang=zh_cn&edition=full","pubTime":"2025-11-05 11:14","pubTimestamp":1762312498,"startTime":"0","endTime":"0","summary":"金吾财讯 | 恒生医疗保健指数日内跌0.3%，医药股普遍走低，圣诺医药-B(02257)跌8.23%，百奥赛图-B(02315)跌5.63%，荣昌生物(09995)跌4.73%，药明巨诺-B(02126)、科笛-B(02487)跌逾4%。","market":"sg","thumbnail":"https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1969055","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","159506","02315","09995","BK1574","02126","BK1515","LU2328871848.SGD","02257","159938","BK1583","BK1161","09939","02487"],"gpt_icon":0},{"id":"2580803274","title":"药明巨诺-B盘中异动 早盘急速下跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580803274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580803274?lang=zh_cn&edition=full","pubTime":"2025-11-04 09:44","pubTimestamp":1762220666,"startTime":"0","endTime":"0","summary":"2025年11月04日早盘09时44分，药明巨诺-B股票出现异动，股价急速跳水5.45%。截至发稿，该股报3.820港元/股，成交量65.85万股，换手率0.16%，振幅8.91%。药明巨诺-B股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，维升药业-B、华康生物医学、帝王国际投资涨幅较大，振幅较大的相关个股有药明巨诺-B、科济药业-B、华康生物医学，振幅分别为8.42%、6.95%、6.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104094426a6df18d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104094426a6df18d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","02126","BK1161"],"gpt_icon":0},{"id":"2580748472","title":"药明巨诺与再生元深化合作 获最高5000万美元里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2580748472","media":"DoNews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580748472?lang=zh_cn&edition=full","pubTime":"2025-11-03 16:58","pubTimestamp":1762160282,"startTime":"0","endTime":"0","summary":"药明巨诺近日宣布与再生元签署战略合作补充协议，进一步拓展双方合作关系。根据协议内容，药明巨诺将有望获得累计最高达5000万美元的款项，涵盖MAGE-A4产品开发、药品及慢病毒载体制造流程中的多项监管里程碑付款，并包括选择权行使费用。此次补充协议的达成，标志着双方在细胞治疗领域研发协作的持续深化，有助于加速关键项目的临床转化与产业化进程。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103170213a6dd7b65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103170213a6dd7b65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","BK1161","02126"],"gpt_icon":0},{"id":"2580255291","title":"港股异动 | 药明巨诺-B涨超12%，报道称其CAR-T药物有望进入商保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2580255291","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580255291?lang=zh_cn&edition=full","pubTime":"2025-11-03 09:59","pubTimestamp":1762135144,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，药明巨诺-B涨超10%，截至发稿，涨9.77%，报3.82港元，成交额463.31万港元。消息面上，据第一财经报道，11月2日，记者获悉，药明巨诺的CAR-T细胞药物瑞基奥仑赛注射液在谈判进入商保 创新药目录方面进展顺利，有望纳入该目录，降低患者用药负担，造福更多患者。这是国内获批上市的第一个国产1类CAR-T，上市后的定价是129万元/针。10月30日，药明巨诺宣布与再生元制药公司签署战略合作补充协议。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"628fecc566bce7ba17e7dea241a462ec","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364258.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","BK4230","BK4022","BK1583","02126"],"gpt_icon":0},{"id":"2580256323","title":"Biotech和大药企全新合作方式，诞生","url":"https://stock-news.laohu8.com/highlight/detail?id=2580256323","media":"瞪羚社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580256323?lang=zh_cn&edition=full","pubTime":"2025-11-03 08:52","pubTimestamp":1762131145,"startTime":"0","endTime":"0","summary":"一种很新的Biotech和大药企之间的交易合作方式已经出现。尽管JWTCR001是引进的管线，但过往中国Biotech的交易历史来看，从未有过在同一个资产下引进方技术反哺授权方并获得技术授权付款的先河，药明巨诺和再生元这一创新式合作补充显然有很多价值挖掘点。01创新交易先河从国内Biotech过往合作交易历史上，与海外药企达成合作无非几种，包括买卖管线权益、技术平台使用授权、药物特许权折现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103085409a483ba71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103085409a483ba71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02126","BK1583","BK1574","BK1161"],"gpt_icon":0},{"id":"2580563362","title":"甘肃将牵头开展心脏瓣膜集采；五款CAR-T药物迎国谈博弈","url":"https://stock-news.laohu8.com/highlight/detail?id=2580563362","media":"21综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580563362?lang=zh_cn&edition=full","pubTime":"2025-11-03 07:59","pubTimestamp":1762127940,"startTime":"0","endTime":"0","summary":"政策动向甘肃将牵头开展心脏瓣膜集采10月31日，甘肃医保局发布《关于邀请参加心脏瓣膜类相关产品企业介绍会的通知》。此外，相关媒体报道显示，药明巨诺的CAR-T细胞药物瑞基奥仑赛注射液在谈判进入商保创新药目录方面进展顺利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110308052494eac49b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110308052494eac49b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02126","BK1583"],"gpt_icon":0},{"id":"2579458712","title":"药明巨诺-B10月31日主力净流入68.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2579458712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579458712?lang=zh_cn&edition=full","pubTime":"2025-10-31 16:15","pubTimestamp":1761898536,"startTime":"0","endTime":"0","summary":"10月31日, 药明巨诺-B股价涨0.87%，报收3.48元，成交金额1069.6万元，换手率0.75%，振幅5.80%，量比1.30。药明巨诺-B今日主力资金净流入68.8万元，上一交易日主力净流出165.5万元。该股近5个交易日下跌0.85%，主力资金累计净流出72.8万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出768.3万元，其中净流出天数为8日。该股主力净额占比0.05%，港股市场排名153/2683。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031161940974beb3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031161940974beb3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","02126","BK1161"],"gpt_icon":0},{"id":"2579489068","title":"药明巨诺-B10月30日主力净流出165.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2579489068","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579489068?lang=zh_cn&edition=full","pubTime":"2025-10-30 16:15","pubTimestamp":1761812109,"startTime":"0","endTime":"0","summary":"10月30日, 药明巨诺-B股价跌4.17%，报收3.45元，成交金额1398.1万元，换手率0.98%，振幅7.50%，量比2.37。药明巨诺-B今日主力资金净流出165.5万元，上一交易日主力净流入37.4万元。该股近5个交易日下跌9.21%，主力资金累计净流出176.2万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出802.9万元，其中净流出天数为8日。该股主力净额占比0.12%，港股市场排名2631/2687。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251030161529a47d5a74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251030161529a47d5a74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","BK1161","02126"],"gpt_icon":0},{"id":"2578589694","title":"药明巨诺-B盘中异动 快速拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578589694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578589694?lang=zh_cn&edition=full","pubTime":"2025-10-27 09:57","pubTimestamp":1761530235,"startTime":"0","endTime":"0","summary":"2025年10月27日早盘09时57分，药明巨诺-B股票出现波动，股价快速拉升5.19%。截至发稿，该股报3.650港元/股，成交量37.9万股，换手率0.09%，振幅6.34%。药明巨诺-B股票所在的生物技术行业中，整体涨幅为2.34%。其相关个股中，歌礼制药-B、北海康成-B、药明合联涨幅较大，振幅较大的相关个股有永泰生物-B股权、北海康成-B、维亚生物，振幅分别为15.94%、9.78%、7.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027095715a4767cb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027095715a4767cb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02126","BK1583"],"gpt_icon":0},{"id":"2577329280","title":"药明巨诺-B盘中异动 早盘股价大跌5.00%报3.610港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577329280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577329280?lang=zh_cn&edition=full","pubTime":"2025-10-23 10:05","pubTimestamp":1761185132,"startTime":"0","endTime":"0","summary":"2025年10月23日早盘10时05分，药明巨诺-B股票出现异动，股价急速下挫5.00%。截至发稿，该股报3.610港元/股，成交量33万股，换手率0.08%，振幅4.74%。资金方面，该股资金流入22.809万港元，流出94.699万港元。药明巨诺-B股票所在的生物技术行业中，整体跌幅为2.03%。其相关个股中，永泰生物-B、维升药业-B、药捷安康-B涨幅较大，振幅较大的相关个股有荃信生物-B、轩竹生物-B、云康集团，振幅分别为12.52%、11.00%、10.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023100532a6c8f641&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023100532a6c8f641&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02126","BK1583"],"gpt_icon":0},{"id":"2577847283","title":"药明巨诺-B(02126)：已向国家药监局递交瑞基奥仑赛在中国成人活动性系统性红斑狼疮患者中的I期研究数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2577847283","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577847283?lang=zh_cn&edition=full","pubTime":"2025-10-21 16:43","pubTimestamp":1761036180,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明巨诺-B 发布公告，已向中国国家药品监督管理局递交瑞基奥仑赛在中国成人活动性系统性红斑狼疮患者中的I期研究数据，NMPA已接收数据，并受理会议申请。SLE是一种慢性自身免疫性疾病，可引起全身多脏器和组织受损。本研究安全性结果表明，瑞基奥仑赛治疗中重度活动性SLE安全性良好。基于此前开展的IIT研究和本次I期临床研究结果，瑞基奥仑赛用于治疗中国成人中重度活动性SLE，整体安全性良好，不良反应可控，疗效显著。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357544.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1574","BK1161","02126"],"gpt_icon":0},{"id":"2576863835","title":"药明巨诺-B盘中异动 股价大涨5.61%报3.950港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576863835","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576863835?lang=zh_cn&edition=full","pubTime":"2025-10-20 10:38","pubTimestamp":1760927885,"startTime":"0","endTime":"0","summary":"2025年10月20日早盘10时38分，药明巨诺-B股票出现异动，股价大幅上涨5.61%。截至发稿，该股报3.950港元/股，成交量22.55万股，换手率0.05%，振幅4.55%。资金方面，该股资金流入50.421万港元，流出32.2175万港元。药明巨诺-B股票所在的生物技术行业中，整体涨幅为2.83%。消息层面，截至10时38分，《必贝特正式开启申购 核心产品商业化前景待考》资讯为影响药明巨诺-B的重要信息。今年1月，必贝特已启动相关上市后的关键性注册研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251020103807a6c2c0c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251020103807a6c2c0c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02126","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2575070277","title":"药明巨诺-B10月14日遭主力抛售282.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575070277","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575070277?lang=zh_cn&edition=full","pubTime":"2025-10-14 16:15","pubTimestamp":1760429707,"startTime":"0","endTime":"0","summary":"10月14日, 药明巨诺-B股价跌3.53%，报收3.83元，成交金额956.9万元，换手率0.59%，振幅8.31%，量比0.93。药明巨诺-B今日主力资金净流出282.6万元，连续3日净流出，上一交易日主力净流出122.4万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为71.43%，平均跌幅为4.07%。该股近5个交易日下跌17.99%，主力资金累计净流出575.4万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出829.3万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014161517a45f320a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014161517a45f320a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02126","BK1583","BK1161"],"gpt_icon":0},{"id":"1170789541","title":"港股生物医药股多数走低，君实生物跌超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1170789541","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170789541?lang=zh_cn&edition=full","pubTime":"2025-10-13 10:19","pubTimestamp":1760321942,"startTime":"0","endTime":"0","summary":"10月13日，港股$生物(000504)$医药股多数走低，$君实生物(01877)$跌超8%，$药明康德(02359)$、$药明巨诺(02126)$、$创胜集团-B(06628)$跌超6%，$药明生物(02269)$跌超5%，$再鼎医药(09688)$、$药明合联(02268)$跌超4%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"331ce596c0fbd116887390ae963da9bb","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02126","01877","02359","BK4614"],"gpt_icon":0},{"id":"2574431079","title":"自免细胞疗法密集披露进展！最快明年 BLA，多家明星企业重点布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2574431079","media":"医麦客","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574431079?lang=zh_cn&edition=full","pubTime":"2025-10-11 07:20","pubTimestamp":1760138441,"startTime":"0","endTime":"0","summary":"不仅如此，还有企业针对这一疾病的“拓展适应症”进行了布局。结果显示，2 例难治性重症肌无力患者的临床症状持续改善超过 18 个月， 且安全性良好，仅 1 例受试者发生了 1 级的细胞因子释放综合征。石药集团基于 mRNA-LNP 的 CAR-T 细胞疗法 SYS6020 在获得系统性红斑狼疮的临床批件后又获得了重症肌无力的临床批件，该候选产品靶向 BCMA，具有细胞活率高、CAR 阳性率高，安全性高的特点。值得一提的是SYS6020 是全球首款获批重症肌无力临床试验的基于 mRNA-LNP 的细胞疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251011072231a459d090&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251011072231a459d090&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02126","BK1161","BK1583","BK1574","01093"],"gpt_icon":0},{"id":"2574123665","title":"过百万的CAR-T药物，价格有望大幅下降？","url":"https://stock-news.laohu8.com/highlight/detail?id=2574123665","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574123665?lang=zh_cn&edition=full","pubTime":"2025-10-10 15:07","pubTimestamp":1760080034,"startTime":"0","endTime":"0","summary":"药明巨诺官网截图截至目前，包括药明巨诺的瑞基奥仑赛注射液在内，国内已获批上市的CAR-T细胞治疗产品数量，已达到7款，但昂贵的价格却限制了产品的可及性，大部分产品价格过百万元，如药明巨诺的瑞基奥仑赛注射液价格达到129万元/针。过往数年，CAR-T细胞治疗产品已四次冲击医保谈判失败。最常见的严重不良事件为血细胞减少，CAR-T相关毒性如CRS，多为1级，无≥3级CRS发生，无任何级别ICANS发生。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251010152100a6b2b601&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251010152100a6b2b601&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","02126","BK1161"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0554},{"period":"1month","weight":-0.0882},{"period":"3month","weight":-0.3854},{"period":"6month","weight":1.1677},{"period":"1year","weight":1.7424},{"period":"ytd","weight":1.8281}],"compareEarnings":[{"period":"1week","weight":0.0126},{"period":"1month","weight":0.0255},{"period":"3month","weight":0.0515},{"period":"6month","weight":0.1382},{"period":"1year","weight":0.3672},{"period":"ytd","weight":0.3247}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明巨诺（开曼）有限公司是一家主要从事细胞免疫治疗产品的研究及开发、生产及上市的公司。该公司建立了一个细胞免疫治疗产品开发的一体化平台以及一条涵盖血液恶性肿瘤、实体瘤及自身免疫性疾病的产品管线。该公司的主要产品倍诺达是该公司在Juno（一家百时美施贵宝的公司）的嵌合抗原受体T细胞（CAR-T）细胞工艺平台的基础上，自主开发的一款靶向CD19的自体CAR-T细胞免疫治疗产品。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.02582},{"month":2,"riseRate":0.8,"avgChangeRate":0.129974},{"month":3,"riseRate":0,"avgChangeRate":-0.16747},{"month":4,"riseRate":0.2,"avgChangeRate":-0.051907},{"month":5,"riseRate":0.6,"avgChangeRate":0.078145},{"month":6,"riseRate":0.4,"avgChangeRate":0.023117},{"month":7,"riseRate":0.4,"avgChangeRate":0.091377},{"month":8,"riseRate":0,"avgChangeRate":-0.160963},{"month":9,"riseRate":0.2,"avgChangeRate":-0.071154},{"month":10,"riseRate":0.2,"avgChangeRate":-0.118018},{"month":11,"riseRate":0.6,"avgChangeRate":0.187345},{"month":12,"riseRate":0.6,"avgChangeRate":-0.035074}],"exchange":"SEHK","name":"药明巨诺-B","nameEN":"JW THERAP-B"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.5","shortVersion":"4.35.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明巨诺-B(02126)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明巨诺-B(02126)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明巨诺-B,02126,药明巨诺-B股票,药明巨诺-B股票老虎,药明巨诺-B股票老虎国际,药明巨诺-B行情,药明巨诺-B股票行情,药明巨诺-B股价,药明巨诺-B股市,药明巨诺-B股票价格,药明巨诺-B股票交易,药明巨诺-B股票购买,药明巨诺-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明巨诺-B(02126)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明巨诺-B(02126)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}